Whit Mayo
Stock Analyst at Leerink Partners
(2.53)
# 2,308
Out of 5,149 analysts
156
Total ratings
53.54%
Success rate
10.45%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AHCO AdaptHealth | Maintains: Outperform | $13 → $12 | $9.40 | +27.66% | 12 | Feb 26, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Market Perform | $14 → $22 | $22.99 | -4.31% | 12 | Feb 26, 2026 | |
| EHAB Enhabit | Maintains: Market Perform | $9.5 → $14 | $13.60 | +1.47% | 3 | Feb 23, 2026 | |
| THC Tenet Healthcare | Maintains: Outperform | $255 → $264 | $242.88 | +8.70% | 15 | Feb 20, 2026 | |
| MD Pediatrix Medical Group | Maintains: Market Perform | $15 → $17 | $19.74 | -13.88% | 11 | Sep 5, 2025 | |
| ELV Elevance Health | Downgrades: Market Perform | $510 → $310 | $284.03 | +9.14% | 4 | Jul 18, 2025 | |
| AIRS AirSculpt Technologies | Maintains: Market Perform | $6.5 → $2.5 | $1.74 | +44.09% | 5 | Mar 31, 2025 | |
| ARDT Ardent Health | Maintains: Outperform | $23 → $25 | $9.41 | +165.67% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $181.58 | +37.68% | 12 | Oct 2, 2024 | |
| EHC Encompass Health | Initiates: Outperform | $100 | $108.01 | -7.42% | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $40.65 | -63.10% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $289.21 | +93.63% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $204.85 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $125.91 | -22.96% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $283.93 | +17.99% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $541.80 | -47.21% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $13.92 | +187.36% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $23.77 | +64.07% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $2.00 | -25.00% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $0.57 | +5,187.28% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $72.52 | +141.31% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $18.45 | +2.98% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.45 | +15.94% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $282.99 | -28.27% | 2 | May 1, 2018 |
AdaptHealth
Feb 26, 2026
Maintains: Outperform
Price Target: $13 → $12
Current: $9.40
Upside: +27.66%
Acadia Healthcare Company
Feb 26, 2026
Maintains: Market Perform
Price Target: $14 → $22
Current: $22.99
Upside: -4.31%
Enhabit
Feb 23, 2026
Maintains: Market Perform
Price Target: $9.5 → $14
Current: $13.60
Upside: +1.47%
Tenet Healthcare
Feb 20, 2026
Maintains: Outperform
Price Target: $255 → $264
Current: $242.88
Upside: +8.70%
Pediatrix Medical Group
Sep 5, 2025
Maintains: Market Perform
Price Target: $15 → $17
Current: $19.74
Upside: -13.88%
Elevance Health
Jul 18, 2025
Downgrades: Market Perform
Price Target: $510 → $310
Current: $284.03
Upside: +9.14%
AirSculpt Technologies
Mar 31, 2025
Maintains: Market Perform
Price Target: $6.5 → $2.5
Current: $1.74
Upside: +44.09%
Ardent Health
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $9.41
Upside: +165.67%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $181.58
Upside: +37.68%
Encompass Health
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $108.01
Upside: -7.42%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $40.65
Upside: -63.10%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $289.21
Upside: +93.63%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $204.85
Upside: -
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $125.91
Upside: -22.96%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $283.93
Upside: +17.99%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $541.80
Upside: -47.21%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $13.92
Upside: +187.36%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $23.77
Upside: +64.07%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $2.00
Upside: -25.00%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $0.57
Upside: +5,187.28%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $72.52
Upside: +141.31%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $18.45
Upside: +2.98%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.45
Upside: +15.94%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $282.99
Upside: -28.27%